SS

Sandrine Silvente-Poirot

Research Director (DR1) at CNRS Co-head of Team INOV "Cholesterol Metabolism and Therapeutic Innovations" Cancer Research Center of Toulouse, CRCT, UMR1037, UMR5071
197
Documents

Compétences

Pharmacology Biochemistry Cancerology

Publications

Publications

Image document

Liver X receptors and the hallmarks of aging: From molecular mechanisms to therapeutic opportunities

Marc Poirot , Julio Buñay , Silia Ayadi , Sandrine Silvente-Poirot , Philippe de Medina
Ageing Research Reviews - ARR, 2026, 114, pp.102967. ⟨10.1016/j.arr.2025.102967⟩
Article dans une revue inserm-05394944 v1
Image document

27-hydroxylation of oncosterone by CYP27A1 switches its activity from pro-tumor to anti-tumor

Silia Ayadi , Silvia Friedrichs , Regis Soulès , Laly Pucheu , Dieter Lütjohann et al.
Journal of Lipid Research, In press, 64 (12), pp.100479. ⟨10.1016/j.jlr.2023.100479⟩
Article dans une revue inserm-04317313 v1
Image document

Chemical synthesis and biochemical properties of cholestane-5α,6β-diol-3-sulfonate: A non-hydrolysable analogue of cholestane-5α,6β-diol-3β-sulfate

Philippe de Medina , Silia Ayadi , Régis Soulès , Bruno Payre , Sandrine Rup-Jacques et al.
Journal of Steroid Biochemistry and Molecular Biology, 2023, 234, pp.106396. ⟨10.1016/j.jsbmb.2023.106396⟩
Article dans une revue hal-04509731 v1
Image document

Is cholesterol a risk factor for breast cancer incidence and outcome?

Céline Ben Hassen , Caroline Goupille , Claire Vigor , Thierry Durand , Françoise Guéraud et al.
Journal of Steroid Biochemistry and Molecular Biology, 2023, 232, pp.106346. ⟨10.1016/j.jsbmb.2023.106346⟩
Article dans une revue hal-04165228 v1
Image document

Targeting the liver X receptor with dendrogenin A differentiates tumour cells to secrete immunogenic exosome‐enriched vesicles

Michel Record , Mehdi Attia , Kevin Carayon , Laly Pucheu , Julio Bunay et al.
Journal of Extracellular Vesicles, 2022, 11 (4), pp.e12211. ⟨10.1002/jev2.12211⟩
Article dans une revue inserm-03649213 v1
Image document

Targeting NR1H/liver X receptor with dendrogenin A differentiates tumor cells to activate a new secretory pathway releasing immunogenic anti-tumor vesicles enriched in LC3-II-associated exosomes

Philippe de Medina , Julio Bunay , Marc Poirot , Michel Record , Sandrine Silvente-Poirot
Autophagy, 2022, 19 (3), pp.1036-1038. ⟨10.1080/15548627.2022.2116175⟩
Article dans une revue inserm-03854248 v1
Image document

Oxysterols are potential physiological regulators of ageing

Philippe de Medina , Sandrine Silvente-Poirot , Marc Poirot
Ageing Research Reviews - ARR, 2022, 77, pp.101615. ⟨10.1016/j.arr.2022.101615⟩
Article dans une revue inserm-03629546 v1
Image document

Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti–PD-1 Therapy Efficacy

Anne Montfort , Florie Bertrand , Julia Rochotte , Julia Gilhodes , Thomas Filleron et al.
Cancer Immunology Research, 2021, 9 (5), pp.568-582. ⟨10.1158/2326-6066.CIR-20-0342⟩
Article dans une revue inserm-03402255 v1
Image document

The 5,6‐epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets

Philippe Medina , Khadijetou Diallo , Emilie Huc‐claustre , Mehdi Attia , Régis Soulès et al.
British Journal of Pharmacology, 2021, 178 (16), pp.3248-3260. ⟨10.1111/bph.15205⟩
Article dans une revue inserm-03394464 v1
Image document

The 5,6-epoxycholesterol metabolic pathway in cancer: emergence of new pharmacological targets

Philippe de Médina , Khadijetou Diallo , Emilie Huc Claustre , Mehdi Attia , Régis Soulès et al.
British Journal of Pharmacology, 2020, 178 (16), pp.3248-3260. ⟨10.22541/au.159069407.75369904⟩
Article dans une revue inserm-03086999 v1
Image document

Dendrogenin A Enhances Anti-Leukemic Effect of Anthracycline in Acute Myeloid Leukemia

Pierre-Luc Mouchel , Nizar Serhan , Rémy Bétous , Thomas Farge , Estelle Saland et al.
Cancers, 2020, 12 (10), pp.2933. ⟨10.3390/cancers12102933⟩
Article dans une revue inserm-03084630 v1
Image document

Dendrogenin A Synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo

Nizar Serhan , Pierre-Luc Mouchel , Philippe de Médina , Gregory Segala , Aurélie Mougel et al.
Cancers, 2020, 12 (7), pp.1725. ⟨10.3390/cancers12071725⟩
Article dans une revue inserm-03084638 v1

The 5,6‐epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets

Philippe Medina , Khadijetou Diallo , Emilie Huc‐claustre , Mehdi Attia , Régis Soulès et al.
British Journal of Pharmacology, 2020, Online ahead of print. ⟨10.1111/bph.15205⟩
Article dans une revue inserm-03084636 v1
Image document

Oxysterols: An expanding family of structurally diversified bioactive steroids

Marc Poirot , Sandrine Silvente-Poirot
Journal of Steroid Biochemistry and Molecular Biology, 2019, 194, pp.105443. ⟨10.1016/j.jsbmb.2019.105443⟩
Article dans une revue inserm-02380490 v1
Image document

HPLC Analysis and Skin Whitening Effects of Umbelliprenin-containing Extracts of Anethum Graveolens, Pimpinella Anisum, and Ferulago Campestris

Vito Taddeo , Francesco Epifano , Francesca Preziuso , Serena Fiorito , Nicolas Caron et al.
Molecules, 2019, 24 (3), pp.501. ⟨10.3390/molecules24030501⟩
Article dans une revue inserm-02380544 v1
Image document

Flavonoids differentially modulate liver X receptors activity—Structure-function relationship analysis

Allan Fouache , Nada Zabaiou , Cyrille de Joussineau , Laurent Morel , Sandrine Silvente-Poirot et al.
Journal of Steroid Biochemistry and Molecular Biology, 2019, 190, pp.173-182. ⟨10.1016/j.jsbmb.2019.03.028⟩
Article dans une revue inserm-02380571 v1
Image document

A fast UPLC–HILIC method for an accurate quantification of dendrogenin A in human tissues

Régis Soules , Fabien Audouard-Combe , Emilie Huc-Claustre , Philippe de Médina , Arnaud Rives et al.
Journal of Steroid Biochemistry and Molecular Biology, 2019, 194, pp.105447. ⟨10.1016/j.jsbmb.2019.105447⟩
Article dans une revue inserm-02380526 v1
Image document

The cholesterol-derived metabolite dendrogenin A functionally reprograms breast adenocarcinoma and undifferentiated thyroid cancer cells

Mathilde Bauriaud-Mallet , Lavinia Vija-Racaru , Séverine Brillouet , Arnaud Mallinger , Philippe de Médina et al.
Journal of Steroid Biochemistry and Molecular Biology, 2019, 192, pp.105390. ⟨10.1016/j.jsbmb.2019.105390⟩
Article dans une revue inserm-02380538 v1
Image document

Natural and semisynthetic oxyprenylated aromatic compounds as stimulators or inhibitors of melanogenesis

Salvatore Genovese , Francesco Epifano , Philippe de Médina , Nicolas Caron , Arnaud Rives et al.
Bioorganic Chemistry, 2019, 87, pp.181-190. ⟨10.1016/j.bioorg.2019.03.026⟩
Article dans une revue inserm-02380542 v1
Image document

The Effects of Cholesterol-Derived Oncometabolites on Nuclear Receptor Function in Cancer

Sandrine Silvente-Poirot , Florence Dalenc , Marc Poirot
Cancer Research, 2018, 78 (17), pp.4803-4808. ⟨10.1158/0008-5472.CAN-18-1487⟩
Article dans une revue inserm-02380586 v1
Image document

The tumor-suppressor cholesterol metabolite, dendrogenin A, is a new class of LXR modulator activating lethal autophagy in cancers

Sandrine Silvente-Poirot , Marc Poirot
Biochemical Pharmacology, 2018, 153, pp.75-81. ⟨10.1016/j.bcp.2018.01.046⟩
Article dans une revue inserm-02380575 v1
Image document

Extracellular vesicles: lipids as key components of their biogenesis and functions

Michel Record , Sandrine Silvente-Poirot , Marc Poirot , Michael J. O. Wakelam
Journal of Lipid Research, 2018, 59 (8), pp.1316-1324. ⟨10.1194/jlr.E086173⟩
Article dans une revue inserm-02380557 v1
Image document

Ligand-dependent transcriptional induction of lethal autophagy: A new perspective for cancer treatment

Sandrine Silvente-Poirot , Gregory Segala , Mathias Poirot , Marc Poirot
Autophagy, 2018, 14 (3), pp.555-557. ⟨10.1080/15548627.2018.1425059⟩
Article dans une revue inserm-02380583 v1
Image document

Bryonolic Acid Blocks Cancer Cell Clonogenicity and Invasiveness through the Inhibition of Fatty Acid: Cholesteryl Ester Formation

Farid Khallouki , Robert Owen , Sandrine Silvente-Poirot , Marc Poirot
Biomedicines, 2018, 6 (1), pp.21. ⟨10.3390/biomedicines6010021⟩
Article dans une revue inserm-02380570 v1
Image document

Chemistry, biochemistry, metabolic fate and mechanism of action of 6-oxo-cholestan-3β,5α-diol (OCDO), a tumor promoter and cholesterol metabolite

Marc Poirot , Régis Soules , Arnaud Mallinger , Florence Dalenc , Sandrine Silvente-Poirot
Biochimie, 2018, 153, pp.139-149. ⟨10.1016/j.biochi.2018.04.008⟩
Article dans une revue inserm-02380564 v1
Image document

Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death

Julie Leignadier , Florence Dalenc , Marc Poirot , Sandrine Silvente-Poirot
Biochemical Pharmacology, 2017, 144, pp.18-28. ⟨10.1016/j.bcp.2017.06.120⟩
Article dans une revue inserm-02380608 v1
Image document

Dendrogenin A drives LXR to trigger lethal autophagy in cancers

Gregory Segala , Marion David , Philippe de Médina , Mathias Poirot , Nizar Serhan et al.
Nature Communications, 2017, 8 (1), pp.1903. ⟨10.1038/s41467-017-01948-9⟩
Article dans une revue inserm-02380591 v1
Image document

Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study

Florence Dalenc , Luiggi Iuliano , Thomas Filleron , Chiara Zerbinati , Maud Voisin et al.
Journal of Steroid Biochemistry and Molecular Biology, 2017, 169, pp.210-218. ⟨10.1016/j.jsbmb.2016.06.010⟩
Article dans une revue inserm-02380620 v1
Image document

Quantitative analysis of the tumor suppressor dendrogenin A using liquid chromatography tandem mass spectrometry

Emmanuel Noguer , Régis Soules , Claude Netter , Citra Nagarathinam , Julie Leignadier et al.
Chemistry and Physics of Lipids, 2017, 207, pp.81-86. ⟨10.1016/j.chemphyslip.2017.06.010⟩
Article dans une revue inserm-02380602 v1
Image document

Improvement of 5,6α-epoxycholesterol, 5,6β-epoxycholesterol, cholestane-3β,5α,6β-triol and 6-oxo-cholestan-3β,5α-diol recovery for quantification by GC/MS

Régis Soules , Emmanuel Noguer , Luigi Iuliano , Chiara Zerbinati , Julie Leignadier et al.
Chemistry and Physics of Lipids, 2017, 207, pp.92-98. ⟨10.1016/j.chemphyslip.2017.05.006⟩
Article dans une revue inserm-02380612 v1
Image document

Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor

Maud Voisin , Philippe de Médina , Arnaud Mallinger , Florence Dalenc , Emilie Huc-Claustre et al.
Proceedings of the National Academy of Sciences of the United States of America, 2017, 114 (44), pp.E9346-E9355. ⟨10.1073/pnas.1707965114⟩
Article dans une revue hal-02316171 v1
Image document

Molecular and Biochemical Analysis of the Estrogenic and Proliferative Properties of Vitamin E Compounds

Farid Khallouki , Philippe de Médina , Stéphanie Caze-Subra , Kerstin Bystricky , Patrick Balaguer et al.
Frontiers in Oncology, 2016, 5, ⟨10.3389/fonc.2015.00287⟩
Article dans une revue hal-02271824 v1
Image document

When cholesterol meets histamine, it gives rise to dendrogenin A: a tumour suppressor metabolite1

Marc Poirot , Sandrine Silvente-Poirot
Biochemical Society Transactions, 2016, 44 (2), pp.631-637. ⟨10.1042/BST20150232⟩
Article dans une revue inserm-02380631 v1

Dendrogenin A: A Mammalian Metabolite of Cholesterol with Tumor Suppressor and Neurostimulating Properties

Florence Dalenc , Marc Poirot , Sandrine Silvente-Poirot
Current Medicinal Chemistry, 2015, 22 (30), pp.3533-3549. ⟨10.2174/0929867322666150716114912⟩
Article dans une revue istex inserm-02380776 v1
Image document

Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies.

Michel Record , Kevin Carayon , Marc Poirot , Sandrine Silvente-Poirot
BBA - Biochimica et Biophysica Acta, 2014, 1841 (1), pp.108-120. ⟨10.1016/j.bbalip.2013.10.004⟩
Article dans une revue inserm-00968935 v1
Image document

One step synthesis of 6-oxo-cholestan-3β,5α-diol.

Maud Voisin , Sandrine Silvente-Poirot , Marc Poirot
Biochemical and Biophysical Research Communications, 2014, 446 (3), pp.782-785. ⟨10.1016/j.bbrc.2014.01.138⟩
Article dans une revue inserm-00968933 v1
Image document

The novel steroidal alkaloids dendrogenin A and B promote proliferation of adult neural stem cells.

Shaden A. M. Khalifa , Philippe de Médina , Anna Erlandsson , Hesham R. El-Seedi , Sandrine Silvente-Poirot et al.
Biochemical and Biophysical Research Communications, 2014, 446 (3), pp.681-686. ⟨10.1016/j.bbrc.2013.12.134⟩
Article dans une revue inserm-00968932 v1
Image document

Cancer. Cholesterol and cancer, in the balance.

Sandrine Silvente-Poirot , Marc Poirot
Science, 2014, 343 (6178), pp.1445-1446. ⟨10.1126/science.1252787⟩
Article dans une revue inserm-00968924 v1
Image document

Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism

Brigitte Sola , Marc Poirot , Philippe de Médina , Sophie Bustany , Véronique Marsaud et al.
Oncotarget, 2013, 4 (6), pp.911-922. ⟨10.18632/oncotarget.1066⟩
Article dans une revue inserm-00968940 v1
Image document

5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of Tamoxifen in breast cancer cells.

Gregory Segala , Philippe de Médina , Luigi Iuliano , Chiara Zerbinati , Michael R. Paillasse et al.
Biochemical Pharmacology, 2013, 86 (1), pp.175-89. ⟨10.1016/j.bcp.2013.02.031⟩
Article dans une revue inserm-00822322 v1
Image document

Technical note: Hapten synthesis, antibody production and development of an enzyme-linked immunosorbent assay for detection of the natural steroidal alkaloid Dendrogenin A.

Philippe de Médina , Michael R. Paillasse , Gregory Segala , Talal Al Saati , Jeannine Boyes et al.
Biochimie, 2013, 95 (3), pp.482-488. ⟨10.1016/j.biochi.2012.06.001⟩
Article dans une revue istex inserm-00822283 v1
Image document

Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties.

Philippe de Médina , Michael R. Paillasse , Gregory Segala , Maud Voisin , Loubna Mhamdi et al.
Nature Communications, 2013, 4, pp.1840. ⟨10.1038/ncomms2835⟩
Article dans une revue inserm-00823974 v1
Image document

Oxysterols and related sterols: Implications in pharmacology and pathophysiology.

Marc Poirot , Sandrine Silvente-Poirot
Biochemical Pharmacology, 2013, 86 (1), pp.1-2. ⟨10.1016/j.bcp.2013.05.001⟩
Article dans une revue istex inserm-00832422 v1
Image document

Cholesterol-5,6-epoxides: Chemistry, biochemistry, metabolic fate and cancer.

Marc Poirot , Sandrine Silvente-Poirot
Biochimie, 2012, 95 (3), pp.622-631. ⟨10.1016/j.biochi.2012.05.006⟩
Article dans une revue istex inserm-00743461 v1
Image document

Surprising unreactivity of cholesterol-5,6-epoxides towards nucleophiles.

Michael R. Paillasse , Nathalie Saffon , Heinz Gornitzka , Sandrine Silvente-Poirot , Marc Poirot et al.
Journal of Lipid Research, 2012, 53 (4), pp.718-725. ⟨10.1194/jlr.M023689⟩
Article dans une revue inserm-00743457 v1
Image document

Cholesterol metabolism and cancer: the good, the bad and the ugly.

Sandrine Silvente-Poirot , Marc Poirot
Current Opinion in Pharmacology, 2012, 12 (6), pp.673-6. ⟨10.1016/j.coph.2012.10.004⟩
Article dans une revue istex inserm-00822284 v1
Image document

Cholesterol metabolism and resistance to tamoxifen.

Marc Poirot , Sandrine Silvente-Poirot , Ralph R. Weichselbaum
Current Opinion in Pharmacology, 2012, 12 (6), pp.683-689. ⟨10.1016/j.coph.2012.09.007⟩
Article dans une revue istex inserm-00743466 v1
Image document

Cholesterol epoxide hydrolase and cancer.

Sandrine Silvente-Poirot , Marc Poirot
Current Opinion in Pharmacology, 2012, 12 (6), pp.696-703. ⟨10.1016/j.coph.2012.07.007⟩
Article dans une revue istex inserm-00743463 v1
Image document

Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands.

Philippe de Médina , Michael R. Paillasse , Gregory Ségala , Farid Khallouki , Severine Brillouet et al.
Chemistry and Physics of Lipids, 2011, 164 (6), pp.432-437. ⟨10.1016/j.chemphyslip.2011.05.005⟩
Article dans une revue istex inserm-00743454 v1
Image document

Exosomes as intercellular signalosomes and pharmacological effectors.

Michel Record , Caroline Subra , Sandrine Silvente-Poirot , Marc Poirot
Biochemical Pharmacology, 2011, 81 (10), pp.1171-1182. ⟨10.1016/j.bcp.2011.02.011⟩
Article dans une revue istex inserm-00743451 v1
Image document

Auraptene is an inhibitor of cholesterol esterification and a modulator of estrogen receptors.

Philippe de Médina , Salvatore Genovese , Michael R. Paillasse , Mahta Mazaheri , Stéphanie Caze-Subra et al.
Molecular Pharmacology, 2010, 78 (5), pp.827-36. ⟨10.1124/mol.110.065250⟩
Article dans une revue inserm-00519166 v1
Image document

Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands.

Philippe de Médina , Michael R. Paillasse , Grégory Segala , Marc E. Poirot , Sandrine Silvente-Poirot
Proceedings of the National Academy of Sciences of the United States of America, 2010, 107 (30), pp.13520-13525. ⟨10.1073/pnas.1002922107⟩
Article dans une revue inserm-00519159 v1
Image document

Synthesis, characterization and in vitro evaluation of new oxorhenium- and oxotechnetium-CCK4 derivatives as molecular imaging agents for CCK2-receptor targeting.

Sandra Dorbes , Béatrice Mestre-Voegtlé , Yvon Coulais , Claude Picard , Sandrine Silvente-Poirot et al.
European Journal of Medicinal Chemistry, 2010, 45 (2), pp.423-429. ⟨10.1016/j.ejmech.2009.09.043⟩
Article dans une revue istex inserm-00519153 v1
Image document

Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: from molecular modeling to in vivo evaluation.

Séverine Brillouet , Sandra Dorbes , Frédéric Courbon , Claude Picard , Jean Pierre Delord et al.
Bioorganic and Medicinal Chemistry, 2010, 18 (14), pp.5400-5412. ⟨10.1016/j.bmc.2010.05.031⟩
Article dans une revue istex inserm-00519158 v1

Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins.

Caroline Subra , David Grand , Karine Laulagnier , Alexandre Stella , Gerard Lambeau et al.
Quarterly Reviews of Biophysics, 2010, 34 (3), epub ahead of print. ⟨10.1194/jlr.M003657⟩
Article dans une revue hal-00497229 v1
Image document

Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism.

Philippe de Médina , Bruno Payré , Nadia Boubekeur , Justine Bertrand-Michel , François Tercé et al.
Cell Death and Differentiation, 2009, 16 (10), pp.1372-1384. ⟨10.1038/cdd.2009.62⟩
Article dans une revue inserm-00519149 v1
Image document

Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion.

Michael R. Paillasse , Philippe de Médina , Guillaume Amouroux , Loubna Mhamdi , Marc E. Poirot et al.
Journal of Lipid Research, 2009, 50 (11), pp.2203-2211. ⟨10.1194/jlr.M800668-JLR200⟩
Article dans une revue inserm-00519146 v1
Image document

Synthesis of new alkylaminooxysterols with potent cell differentiating activities: identification of leads for the treatment of cancer and neurodegenerative diseases.

Philippe de Médina , Michael R. Paillasse , Bruno Payré , Sandrine Silvente-Poirot , Marc E. Poirot
Journal of Medicinal Chemistry, 2009, 52 (23), pp.7765-7777. ⟨10.1021/jm901063e⟩
Article dans une revue inserm-00519151 v1
Image document

Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation.

Philippe de Médina , Sandrine Silvente-Poirot , Marc E. Poirot
Autophagy, 2009, 5 (7), pp.1066-1067. ⟨10.4161/auto.5.7.9820⟩
Article dans une revue inserm-00519150 v1
Image document

Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism.

Bruno Payré , Philippe de Médina , Nadia Boubekeur , Loubna Mhamdi , Justine Bertrand-Michel et al.
Molecular Cancer Therapeutics, 2008, 7 (12), pp.3707-3718. ⟨10.1158/1535-7163.MCT-08-0507⟩
Article dans une revue inserm-00519145 v1
Image document

Insights into the cholecystokinin 2 receptor binding site and processes of activation.

Michaël Paillasse , Céline Deraeve , Philippe de Médina , Loubna Mhamdi , Gilles Favre et al.
Molecular Pharmacology, 2006, 70 (6), pp.1935-1945. ⟨10.1124/mol.106.029967⟩
Article dans une revue inserm-00519168 v1
Image document

The prototypical inhibitor of cholesterol esterification, Sah 58-035 [3-[decyldimethylsilyl]-n-[2-(4-methylphenyl)-1-phenylethyl]propanamide], is an agonist of estrogen receptors

Philippe de Médina , Nadia Boubekeur , Patrick Balaguer , Gilles Favre , Sandrine Silvente-Poirot et al.
Journal of Pharmacology and Experimental Therapeutics, 2006, 319 (1), pp.139-149. ⟨10.1124/jpet.106.104349⟩
Article dans une revue inserm-00090770 v1
Image document

The peripheral cholecystokinin receptors

Sandrine Silvente-Poirot , Marlène Dufresne , Nicole Vaysse , Daniel Fourmy
European Journal of Biochemistry, 2005, 215 (3), pp.513-529. ⟨10.1111/j.1432-1033.1993.tb18061.x⟩
Article dans une revue inserm-04974721 v1
Image document

Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells.

Philippe de Médina , Bruno Payré , José Bernad , Isabelle Bosser , Bernard Pipy et al.
Journal of Pharmacology and Experimental Therapeutics, 2004, 308 (3), pp.1165-1173. ⟨10.1124/jpet.103.060426⟩
Article dans une revue inserm-00090774 v1
Image document

Molecular characterization of the microsomal tamoxifen binding site.

Blandine Kedjouar , Philippe de Médina , Mustapha Oulad-Abdelghani , Bruno Payré , Sandrine Silvente-Poirot et al.
Journal of Biological Chemistry, 2004, 279 (32), pp.34048-34061. ⟨10.1074/jbc.M405230200⟩
Article dans une revue inserm-00090773 v1
Image document

Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies.

Céline Galés , Marc E. Poirot , Julien Taillefer , Bernard Maigret , Jean Martinez et al.
Molecular Pharmacology, 2003, 63, pp.973-982. ⟨10.1124/mol.63.5.973⟩
Article dans une revue inserm-00090776 v1
Image document

High tumorigenic potential of a constitutively active mutant of the cholecystokinin 2 receptor.

Céline Galés , Didier Sanchez , Marc E. Poirot , Stéphane Pyronnet , Louis Buscail et al.
Oncogene, 2003, 22, pp.6081-6089. ⟨10.1038/sj.onc.1206823⟩
Article dans une revue inserm-00090775 v1
Image document

The Biologically Crucial C Terminus of Cholecystokinin and the Non-peptide Agonist SR-146,131 Share a Common Binding Site in the Human CCK1 Receptor

Chantal Escrieut , Véronique Gigoux , Elodie Archer , Sophie Verrier , Bernard Maigret et al.
Journal of Biological Chemistry, 2002, 277 (9), pp.7546-7555. ⟨10.1074/jbc.M108563200⟩
Article dans une revue inserm-04974775 v1

structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists

Daniel Fourmy , Chantal Escrieu , Elodie Archer , Céline Galès , Véronique Gigoux et al.
Pharmacology and Toxicology -Copenhagen-, 2002, 91, pp.313-320
Article dans une revue hal-00358676 v1

The Third Intracellular Loop of the Rat and Mouse Cholecystokinin-A Receptors Is Responsible for Different Patterns of Gene Activation

Roya Poosti , Laure Di Malta , Didier Gagne , Nicole Bernad , Jean-Claude Galleyrand et al.
Molecular Pharmacology, 2000, 58 (6), pp.1381-1388. ⟨10.1124/mol.58.6.1381⟩
Article dans une revue inserm-04974769 v1
Image document

Mutation of Asn-391 within the Conserved NPXXY Motif of the Cholecystokinin B Receptor Abolishes Gq Protein Activation without Affecting Its Association with the Receptor

Céline Galés , Aline Kowalski-Chauvel , Marie Noelle Dufour , Catherine Seva , Luis Moroder et al.
Journal of Biological Chemistry, 2000, 275 (23), pp.17321-17327. ⟨10.1074/jbc.M909801199⟩
Article dans une revue inserm-04974763 v1
Image document

Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin

Véronique Gigoux , Chantal Escrieu , Jean-Alain Fehrentz , Sandrine Silvente-Poirot , Bernard Maigret et al.
Journal of Biological Chemistry, 1999, 274 (29), pp.20457-20464. ⟨10.1074/jbc.274.29.20457⟩
Article dans une revue hal-00357552 v1

evidence for a direct inetraction between the penultimate aspartic acid of cholecystokinin and histidine 207, located in the second extracellular loop of the cholecystokinin B receptor

Sandrine Silvente-Poirot , Chantal Escrieu , Céline Galès , Jean-Alain Fehrentz , Achim Escherich et al.
Journal of Biological Chemistry, 1999, 274 (33), pp.23191-23197
Article dans une revue hal-00357548 v1
Image document

Evidence for a Direct Interaction between the Penultimate Aspartic Acid of Cholecystokinin and Histidine 207, Located in the Second Extracellular Loop of the Cholecystokinin B Receptor

Sandrine Silvente-Poirot , Chantal Escrieut , Céline Galès , Jean-Alain Fehrentz , Achim Escherich et al.
Journal of Biological Chemistry, 1999, 274 (33), pp.23191-23197. ⟨10.1074/jbc.274.33.23191⟩
Article dans une revue inserm-04974753 v1

Arginine 197 of the cholecystokinin a receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin

Véronique Gigoux , Bernard Maigret , Chantal Escrieu , Sandrine Silvente-Poirot , Michelle Buisson et al.
Protein Science, 1999, 8 (11), pp.2347-2354. ⟨10.1110/ps.8.11.2347⟩
Article dans une revue hal-00357556 v1
Image document

Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state

Véronique Gigoux , Chantal Escrieu , Sandrine Silvente-Poirot , Bernard Maigret , Laurent Goullieux et al.
Journal of Biological Chemistry, 1998, 273 (23), pp.14380-14386. ⟨10.1074/jbc.273.23.14380⟩
Article dans une revue hal-00357491 v1

Role of the Extracellular Domains of the Cholecystokinin Receptor in Agonist Binding

Sandrine Silvente-Poirot , Chantal Escrieut , Stephen Wank
Molecular Pharmacology, 1998, 54 (2), pp.364-371. ⟨10.1124/mol.54.2.364⟩
Article dans une revue inserm-04974746 v1
Image document

Ligand-induced Internalization of Cholecystokinin Receptors

Markus Pohl , Sandrine Silvente-Poirot , Joseph Pisegna , Nadya Tarasova , Stephen Wank
Journal of Biological Chemistry, 1997, 272 (29), pp.18179-18184. ⟨10.1074/jbc.272.29.18179⟩
Article dans une revue inserm-04974735 v1
Image document

A Segment of Five Amino Acids in the Second Extracellular Loop of the Cholecystokinin-B Receptor Is Essential for Selectivity of the Peptide Agonist Gastrin

Sandrine Silvente-Poirot , Stephen Wank
Journal of Biological Chemistry, 1996, 271 (25), pp.14698-14706. ⟨10.1074/jbc.271.25.14698⟩
Article dans une revue inserm-04974732 v1

Electric properties of photoaffinity-labelled pancreatic A-subtype cholecystokinin

J. Jiménez , M. Dufresne , Sandrine Silvente-Poirot , N. Vaysse , Daniel Fourmy
Journal of Chromatography B - Analytical Technologies in the Biomedical and Life Sciences, 1990, 511, pp.333-9. ⟨10.1016/s0021-9673(01)93296-0⟩
Article dans une revue inserm-04974698 v1

PHYTOSTEROL DERIVATIVES, AND COMPOSITIONS COMPRISING THE SAME, FOR USE AS MEDICAMENTS

Sandrine Silvente-Poirot , Philippe de Medina , M Poirot
France, Patent n° : EP2025064259. 2025
Brevet inserm-05110310 v1

Methods for the treatment of cancers

Sandrine Silvente-Poirot , Julio Buñay , Michel Record , Philippe de Medina , M Poirot
France, Patent n° : EP25305623.8. 2025
Brevet inserm-05110314 v1

Phytosterol derivatives, and compositions comprising the same, for use as medicaments

Marc Poirot , Philippe de Medina , Sandrine Silvente-Poirot
France, Patent n° : EP24305827. 2024
Brevet inserm-04773991 v1

Methods for the treatment of breast cancer

Marc Poirot , Philippe de Medina , Khadijetou Diallo , Sandrine Silvente-Poirot
France, Patent n° : EP2430515.8.2024. 2024
Brevet inserm-04773966 v1

Radiotraceurs de tomographie par émission de positrons (TEP) de fluoro-oxystérols

Marc Poirot , Frédéric Courbon , Mohammad Samadi , Philippe de Medina , Sandrine Silvente-Poirot et al.
France, N° de brevet: WO2024146880A1. 2024
Brevet inserm-04773942 v1

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REPROGRAMING IMMUNE ENVIRONMENT IN A SUBJECT IN NEED THEREOF

Marc Poirot , Julie Leignadier , Philippe de Medina , Michel Record , Sandrine Silvente-Poirot
United States, Patent n° : US2023138400A1. 2023
Brevet inserm-04773900 v1

Fluoro-oxysterols positron emission tomography (PET) radiotracers

Marc Poirot , Frédéric Courbon , Mohammad Samadi , Philippe de Medina , Sandrine Silvente-Poirot et al.
France, Patent n° : European patent, EP23305003.8. 2023
Brevet hal-04842549 v1

PROCEDE POUR LA PREPARATION DE DERIVES DE STEROL

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
Canada, N° de brevet: CA2856609C. 2021
Brevet inserm-04772970 v1

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REPROGRAMING IMMUNE ENVIRONMENT IN A SUBJECT IN NEED THEREOF

Marc Poirot , Julie Leignadier , Philippe de Medina , Michel Record , Sandrine Silvente-Poirot
United States, Patent n° : US2020016177A1. 2020
Brevet inserm-04773893 v1

Dendrogenin A and antineoplastic agents for the treatment of chemosensitive or chemoresistant tumors

Marc Poirot , Philippe de Medina , Michaël Paillasse , Christian Récher , Sandrine Silvente-Poirot
France, Patent n° : US10188666B2. 2019
Brevet inserm-04773745 v1

Dendrogenina A y agentes antineoplásicos para el tratamiento de tumores quimiosensibles o quimiorresistentes

Marc Poirot , Philippe de Medina , Michaël Paillasse , Christian Récher , Sandrine Silvente-Poirot
España, N° de brevet: ES2734425T3. 2019
Brevet inserm-04773729 v1

DENDROGÉNINE A ET AGENTS ANTINÉOPLASTIQUES POUR LE TRAITEMENT DES TUMEURS CHIMIOSENSITIVES OU CHIMIORÉSISTANTES

Marc Poirot , Philippe de Medina , Michaël Paillasse , Christian Récher , Sandrine Silvente-Poirot
France, N° de brevet: EP3272350B1. 2019
Brevet inserm-04773717 v1

MÉTHODES ET COMPOSITIONS PHARMACEUTIQUES PERMETTANT LA REPROGRAMMATION DE L'ENVIRONNEMENT IMMUNITAIRE CHEZ UN SUJET EN AYANT BESOIN

Marc Poirot , Julie Leignadier , Philippe de Medina , Michel Record , Sandrine Silvente-Poirot
France, N° de brevet: EP3515453A1. 2019
Brevet inserm-04773879 v1

癌の診断法及びデンドロゲニンAを用いての処置に対する癌の応答を予測する方法

Marc Poirot , Emmanuel Noguer , Sandrine Silvente-Poirot
France, Patent n° : JP2018503064A. 2018
Brevet inserm-04773867 v1

甾醇衍生物的制备方法

Marc Poirot , Michaël Paillasse , Philippe de Medina , Sandrine Silvente-Poirot
China, Patent n° : CN104039807B. 2018
Brevet inserm-04773150 v1

MÉTHODES ET COMPOSITIONS PHARMACEUTIQUES PERMETTANT LA REPROGRAMMATION DE L'ENVIRONNEMENT IMMUNITAIRE CHEZ UN SUJET EN AYANT BESOIN

Marc Poirot , Julie Leignadier , Philippe de Medina , Michel Record , Sandrine Silvente-Poirot
France, N° de brevet: WO2018055080A1. 2018
Brevet inserm-04773906 v1

DENDROGÉNINE A ET AGENTS ANTINÉOPLASTIQUES POUR LE TRAITEMENT DES TUMEURS CHIMIOSENSITIVES OU CHIMIORÉSISTANTES

Marc Poirot , Philippe de Medina , Michaël Paillasse , Christian Récher , Sandrine Silvente-Poirot
France, N° de brevet: EP3272350A1. 2018
Brevet inserm-04773712 v1

METHODS OF DIAGNOSING AND TREATING CANCER

Marc Poirot , Sandrine Silvente-Poirot
United States, Patent n° : US2018231556A1. 2018
Brevet inserm-04773847 v1

Sales de adición de ácidos de 5alfa-hidroxi-6beta-[2-(1H-imidazol-4-il)etilamino]colestan-3beta-ol

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
Francia, N° de brevet: ES2650914T3. 2018
Brevet inserm-04772765 v1

Endrogenina A y agentes antineoplásicos para el tratamiento de tumores quimiosensibles o quimiorresistentes

Marc Poirot , Philippe de Medina , Michaël Paillasse , Christian Récher , Sandrine Silvente-Poirot
España, N° de brevet: ES2656913T3. 2018
Brevet inserm-04773723 v1

DENDROGÉNINE A ET AGENTS ANTINÉOPLASTIQUES POUR LE TRAITEMENT DES TUMEURS CHIMIOSENSITIVES OU CHIMIORÉSISTANTES

Marc Poirot , Philippe de Medina , Michaël Paillasse , Christian Récher , Sandrine Silvente-Poirot
France, N° de brevet: EP3041477B1. 2017
Brevet inserm-04773704 v1

Process for the preparation of sterol derivatives

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
Austria, Patent n° : AU2012342460B2. 2017
Brevet inserm-04772907 v1

ACID ADDITION SALTS OF 5a-HYDROXY-6ß-[2-(1H-IMIDAZOL-4-YL)ETHYL AMINO]CHOLESTAN-3ß-OL.

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
Mexico, Patent n° : MX351610B. 2017
Brevet inserm-04772804 v1

processo para o preparo de derivados de esterol

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
Brazil, Patent n° : BR112014012458A2. 2017
Brevet inserm-04772921 v1

METHODS OF DIAGNOSING AND TREATING CANCER

Marc Poirot , Sandrine Silvente-Poirot
United States, Patent n° : US2017234881A1. 2017
Brevet inserm-04773829 v1

癌を診断及び処置する方法

Marc Poirot , Sandrine Silvente-Poirot
Japan, Patent n° : JP2017527290A. 2017
Brevet inserm-04773842 v1

METHODS OF DIAGNOSING CANCER AND OF PREDICTING RESPONSE OF CANCER TO DENDROGENIN A TREATMENT

Marc Poirot , Sandrine Silvente-Poirot , Emmanuel Noguer
United States, Patent n° : US2017321283A1. 2017
Brevet inserm-04773868 v1

ACID ADDITION SALTS OF 5ALPHA-HYDROXY-6BETA -[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3BETA -OL

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, Patent n° : EP2768841B1. 2017
Brevet inserm-04772755 v1

Methods for Determining the Oncogenic Condition of Cell, Uses Thereof, and Methods for Treating Cancer

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, Patent n° : US2017176446A1. 2017
Brevet inserm-04772284 v1

MÉTHODES DE DIAGNOSTIC ET DE TRAITEMENT DU CANCER

Marc Poirot , Sandrine Silvente-Poirot
France, N° de brevet: EP3194615A1. 2017
Brevet inserm-04773835 v1

ステロール誘導体の調製方法

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, Patent n° : JP6157492B2. 2017
Brevet inserm-04773268 v1

MÉTHODES DE DIAGNOSTIC DU CANCER ET DE PRÉDICTION DE RÉPONSE DU CANCER À UN TRAITEMENT À LA DENDROGÉNINE

Marc Poirot , Emmanuel Noguer , Sandrine Silvente-Poirot
France, N° de brevet: EP3221467A1. 2017
Brevet inserm-04773861 v1

Proceso para la preparación de derivados de esterol

Marc Poirot , Michaël Paillasse , Philippe de Medina , Sandrine Silvente-Poirot
España, N° de brevet: ES2613753T3. 2017
Brevet inserm-04773222 v1

PROCÉDÉ DE PRÉPARATION DE DÉRIVÉS DE STÉROL

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, N° de brevet: EP2782923B1. 2016
Brevet inserm-04773181 v1

METHODES DE DIAGNOSTIC DU CANCER ET DE PREDICTION DE REPONSE DU CANCER A UN TRAITEMENT A LA DENDROGENINE

Marc Poirot , Emmanuel Noguer , Sandrine Silvente-Poirot
Canada, N° de brevet: CA2968002A1. 2016
Brevet inserm-04773858 v1

PROCESS FOR THE PREPARATION OF STEROL DERIVATIVES

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
Mexico, Patent n° : MX343787B. 2016
Brevet inserm-04773308 v1

Process for the preparation of sterol derivatives

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
United States, Patent n° : US9447141B2. 2016
Brevet inserm-04773449 v1

MÉTHODES POUR DÉTERMINER L'ÉTAT ONCOGÉNIQUE D'UNE CELLULE, LEURS APPLICATIONS, ET MÉTHODES POUR TRAITER LE CANCER

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, N° de brevet: EP2446276B9. 2016
Brevet inserm-04772270 v1

DENDROGÉNINE A ET AGENTS ANTINÉOPLASTIQUES POUR LE TRAITEMENT DES TUMEURS CHIMIOSENSITIVES OU CHIMIORÉSISTANTES

Marc Poirot , Philippe de Medina , Michaël Paillasse , Christian Récher , Sandrine Silvente-Poirot
France, N° de brevet: EP3041477A1. 2016
Brevet inserm-04773700 v1

化学療法感受性又は化学療法抵抗性腫瘍の治療のためのデンドロゲニンA及び抗腫瘍薬

Marc Poirot , Philippe de Medina , Michaël Paillasse , Christian Récher , Sandrine Silvente-Poirot
Japan, Patent n° : JP2016532709A. 2016
Brevet inserm-04773739 v1

Dendrogenin A and antineoplastic agents for the treatment of chemosensitive or chemoresistant tumors

Marc Poirot , Philippe de Medina , Michaël Paillasse , Christian Récher , Sandrine Silvente-Poirot
Australia, Patent n° : AU2014317117A1. 2016
Brevet inserm-04773484 v1

MÉTHODES DE DIAGNOSTIC ET DE TRAITEMENT DU CANCER

Marc Poirot , Sandrine Silvente-Poirot
France, N° de brevet: WO2016034742A1. 2016
Brevet inserm-04773852 v1

DENDROGENIN A AND ANTINEOPLASTIC AGENTS FOR THE TREATMENT OF CHEMOSENSITIVE OR CHEMORESISTANT TUMORS

Marc Poirot , Philippe de Medina , Michaël Paillasse , Christian Récher , Sandrine Silvente-Poirot
United States, Patent n° : US2016193233A1. 2016
Brevet inserm-04773751 v1

METHODES DE DIAGNOSTIC ET DE TRAITEMENT DU CANCER

Marc Poirot , Sandrine Silvente-Poirot
Canada, N° de brevet: CA2960036A1. 2016
Brevet inserm-04773830 v1

Dendrogenin A and antineoplastic agents for the treatment of chemosensitive or chemoresistant tumors

Marc Poirot , Philippe de Medina , Michaël Paillasse , Christian Récher , Sandrine Silvente-Poirot
China, Patent n° : CN105611934A. 2016
Brevet inserm-04773695 v1

MÉTHODES DE DIAGNOSTIC DU CANCER ET DE PRÉDICTION DE RÉPONSE DU CANCER À UN TRAITEMENT À LA DENDROGÉNINE

Marc Poirot , Sandrine Silvente-Poirot , Emmanuel Noguer
France, N° de brevet: WO2016079057A1. 2016
Brevet inserm-04773871 v1

DENDROGÉNINE A ET AGENTS ANTINÉOPLASIQUES POUR LE TRAITEMENT DE TUMEURS CHIMIOSENSIBLES OU CHIMIORÉSISTANTES

Marc Poirot , Philippe de Medina , Michaël Paillasse , Christian Récher , Sandrine Silvente-Poirot
France, N° de brevet: WO2015032838A1. 2015
Brevet inserm-04773825 v1

СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ СТЕРИНА

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, Patent n° : RU2014125435A. 2015
Brevet inserm-04773440 v1

КИСЛОТНО-АДДИТИВНЫЕ СОЛИ 5α-ГИДРОКСИ-6β-[2-(1H-ИМИДАЗОЛ-4-ИЛ)ЭТИЛАМИНО]ХОЛЕСТАН-3β-ОЛА

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
Russia, Patent n° : RU2014119929A. 2015
Brevet inserm-04772821 v1

DENDROGENINE A ET AGENTS ANTINEOPLASIQUES POUR LE TRAITEMENT DE TUMEURS CHIMIOSENSIBLES OU CHIMIORESISTANTES

Marc Poirot , Philippe de Medina , Michaël Paillasse , Christian Récher , Sandrine Silvente-Poirot
Canada, N° de brevet: CA2922715A1. 2015
Brevet inserm-04773546 v1

PROCESS FOR THE PREPARATION OF STEROL DERIVATIVES

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
India, Patent n° : IN976MUN2014A. 2015
Brevet inserm-04773233 v1

ステロール誘導体の調製方法

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
Japan, Patent n° : JP2015502934A. 2015
Brevet inserm-04773250 v1

ACID ADDITION SALTS OF 5ALFA-HYDROXY-6BETA-[2-(1H-IMIDAZOL-4-YL)ETHYL AMINO]CHOLESTAN-3BETA-OL.

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
Mexico, Patent n° : MX2014004744A. 2015
Brevet inserm-04772791 v1

PROCESS FOR THE PREPARATION OF STEROL DERIVATIVES

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
South Africa, Patent n° : ZA201403736B. 2015
Brevet inserm-04773467 v1

細胞の腫瘍形成状態を決定する方法、その使用、及び癌の治療方法

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, Patent n° : JP5765587B2. 2015
Brevet inserm-04772280 v1

Aminoalkylsterol compounds with antitumoral and neuroprotective activity

Marc Poirot , Sandrine Silvente-Poirot , Philippe de Medina
France, Patent n° : US8957055B2. 2015
Brevet inserm-04772244 v1

METHODS FOR DETERMINING THE ONCOGENIC CONDITION OF CELL, USES THEREOF, AND METHODS FOR TREATING CANCER

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, Patent n° : PL2446276T3. 2015
Brevet inserm-04772282 v1

PROCESS FOR THE PREPARATION OF STEROL DERIVATIVES

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
Mexico, Patent n° : MX2014006303A. 2014
Brevet inserm-04773301 v1

5α−ヒドロキシ−6β−[2−(1H−イミダゾール−4−イル)エチルアミノ]コレスタン−3β−オールの酸付加塩

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
Japan, Patent n° : JP2014530245A. 2014
Brevet inserm-04772775 v1

Acid addition salts of 5alpha-hydroxy-6beta-[2-(1H-imidazol-4-yl)ethylamino]cholestan-3beta-ol

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, Patent n° : AU2012324980A1. 2014
Brevet inserm-04772297 v1

ACID ADDITION SALTS OF 5α-HYDROXY-6β-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3β-OL

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
South Korea, Patent n° : KR20140083014A. 2014
Brevet inserm-04772786 v1

PROCESS FOR THE PREPARATION OF STEROL DERIVATIVES

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
United States, Patent n° : US2014309417A1. 2014
Brevet inserm-04773447 v1

PROCESS FOR THE PREPARATION OF STEROL DERIVATIVES.

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
Mexico, Patent n° : MX2014006303A. 2014
Brevet inserm-04773292 v1

PROCESS FOR THE PREPARATION OF STEROL DERIVATIVES

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
United States, Patent n° : US2014309417A1. 2014
Brevet inserm-04772885 v1

PROCÉDÉ DE PRÉPARATION DE DÉRIVÉS DE STÉROL

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, N° de brevet: EP2782923A1. 2014
Brevet inserm-04773167 v1

ACID ADDITION SALTS OF 5ALPHA-HYDROXY-6BETA-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3BETA-OL

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
United States, Patent n° : US2014274984A1. 2014
Brevet inserm-04772841 v1

Process for the preparation of sterol derivatives

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
China, Patent n° : CN104039807A. 2014
Brevet inserm-04773135 v1

Acid addition salts of 5[alpha]-hydroxy-6[beta]-[2-(1h-imidazol-4-yl)ethylamino]cholestan-3[beta]-ol

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, Patent n° : CN103958541A. 2014
Brevet inserm-04772748 v1

Process for the preparation of sterol derivatives

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
Austria, Patent n° : AU2012342460A1. 2014
Brevet inserm-04772895 v1

Methods for determining the oncogenic condition of cell, uses thereof, and methods for treating cancer

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, Patent n° : CN102498404B. 2014
Brevet inserm-04772266 v1

PROCESS FOR THE PREPARATION OF STEROL DERIVATES

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
South Korea, Patent n° : KR20140098131A. 2014
Brevet inserm-04773285 v1

PROCEDE POUR LA PREPARATION DE DERIVES DE STEROL

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
Canada, N° de brevet: CA2856609A1. 2013
Brevet inserm-04772952 v1

SELS D'ADDITION D'ACIDE DE 5Alpha-HYDROXY-6Beta-[2-(1H-IMIDAZOL-4-YL)- ÉTHYLAMINO]CHOLESTAN-3Beta-OL

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, N° de brevet: WO2013057148A1. 2013
Brevet inserm-04772848 v1

PROCÉDÉ POUR LA PRÉPARATION DE DÉRIVÉS DE STÉROL

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, N° de brevet: WO2013076257A1. 2013
Brevet inserm-04773460 v1

SELS D'ADDITION D'ACIDE DE 5'-HYDROXY-6'-[2-(1H-IMIDAZOL-4-YL)- ETHYLAMINO]CHOLESTAN-3'-OL

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, N° de brevet: CA2852622A1. 2013
Brevet inserm-04772735 v1

Aminoalkylsterol compounds with antitumoral and neuroprotective activity

Marc Poirot , Sandrine Silvente-Poirot , Philippe de Medina
France, Patent n° : US8524694B2. 2013
Brevet inserm-04772236 v1

Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity

Marc Poirot , Sandrine Silvente-Poirot , Philippe de Medina
France, Patent n° : US7947668B2. 2011
Brevet inserm-04772230 v1

DETECTION DE L'ETAT ONCOGENE DE CELLULES HUMAINES OU DE MAMMIFERES PAR PRESENCE D'UN MARQUEUR ET EVALUATION DE L'ACTIVITE D'UN MEDICAMENT PAR DOSAGE DUDIT MARQUEUR

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, Patent n° : FR2947340B1. 2011
Brevet inserm-04772274 v1

METHODES POUR DETERMINER L'ETAT ONCOGENIQUE D'UNE CELLULE, LEURS APPLICATIONS, ET METHODES POUR TRAITER LE CANCER

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, Patent n° : CA2766011A1. 2010
Brevet inserm-04772259 v1

Aminoalkylsterol compounds having antitumor and neuroprotective activity

Marc Poirot , Sandrine Silvente-Poirot , Philippe de Medina
France, Patent n° : JP4601297B2. 2010
Brevet inserm-04772227 v1

MÉTHODES POUR DÉTERMINER L'ÉTAT ONCOGÉNIQUE D'UNE CELLULE, LEURS APPLICATIONS, ET MÉTHODES POUR TRAITER LE CANCER

Marc Poirot , Sandrine Silvente-Poirot , Michaël Paillasse , Philippe de Medina
France, N° de brevet: WO2010149941A1. 2010
Brevet inserm-04772286 v1

AMINOALKYLSTERINVERBINDUNGEN MIT ANTI-KREBS UND NEUROPROTEKTIVER AKTIVITÄT

Marc Poirot , Philippe de Medina , Sandrine Silvente-Poirot
France, Patent n° : ATE420888T1. 2009
Brevet inserm-04772185 v1

COMPUESTOS AMINOALQUILESTEROLES CON ACTIVIDAD ANTITUMORAL Y NEUROPROTECTORA

Marc Poirot , Sandrine Silvente-Poirot , Philippe de Medina
France, Patent n° : ES2321287T3. 2009
Brevet inserm-04772212 v1

AMINOALKYL STEROL COMPOUNDS HAVING AN ANTI-TUMORAL AND NEUROPROTECTIVE ACTIVITY

Marc Poirot , Sandrine Silvente-Poirot , Philippe de Medina
France, Patent n° : EP1497309B1. 2009
Brevet inserm-04772209 v1

Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity

Philippe de Medina , Sandrine Silvente-Poirot , Marc Poirot
France, Patent n° : AU2003262422B8. 2008
Brevet inserm-04772197 v1

COMPOSES AMINOALKYLSTEROLES AVEC ACTIVITE ANTI-TUMEUR ET NEUROPROTECTRICE

Marc Poirot , Philippe de Medina , Sandrine Silvente-Poirot
France, Patent n° : EP1497309A2. 2005
Brevet inserm-04772177 v1

STEROL DERIVATIVES, METHOD FOR THE PREPARATION THEREOF AND MEDICAMENTS COMPRISING SAME

Marc Poirot , Philippe de Medina , Sandrine Silvente-Poirot
France, Patent n° : WO03089449A2. 2003
Brevet inserm-04772249 v1

AMINOALKYL STEROL COMPOUNDS HAVING AN ANTI-TUMORAL AND NEUROPROTECTIVE ACTIVITY

Marc Poirot , Philippe de Medina , Sandrine Silvente-Poirot
France, Patent n° : CA2481561A1. 2003
Brevet inserm-04772202 v1

Cholesterol and cancer

M Poirot , Sandrine Silvente-Poirot
WebiNacre, réseau NaCRE, Jul 2024, Paris ( virtual ), France
Communication dans un congrès inserm-05029268 v1

Oxysterols

M Poirot , Sandrine Silvente-Poirot
Toulouse school of lipids, Inserm, Feb 2024, Toulouse, France
Communication dans un congrès inserm-05029054 v1

Chemical synthesis and biochemical properties of cholestane-5α,6β-diol-3-sulfonate, a non-hydrolysable analogue of cholestane-5α,6β-diol-3β-sulfate

Philippe de Medina , Silia Ayadi , Regis Soules , Bruno Payre , Sandrine Rup-Jacques et al.
12th ENOR symposium : Importance of Oxysterols in Nutrition, Cancer, and Other Degenerative Diseases, ENOR, Sep 2023, Toulouse, France
Communication dans un congrès inserm-05029639 v1

Biochemical and structural evidences that the human glutathion S-transferase A1 catalyzes the biosynthesis of dendrogenins.

Silia Ayadi , Georges Ndikoum-Matip , Philippe de Medina , Regis Soules , Virginie Nahoum et al.
12th ENOR symposium, Importance of Oxysterols in Nutrition, Cancer, and Other Degenerative Diseases, ENOR, Sep 2023, Toulouse, France
Communication dans un congrès inserm-05029665 v1

Metabolic switching from tumor promoter activities of oncosterone and 27-hydroxycholesterol to 27-hydroxy-oncosterone with antiproliferative properties

Silia Ayadi , Silvia Friedrichs , Regis Soulès , Laly Pucheu , Dieter Lütjohann et al.
12th ENOR symposium, Importance of Oxysterols in Nutrition, Cancer, and Other Degenerative Diseases, ENOR, Sep 2023, Toulouse, France
Communication dans un congrès inserm-05029635 v1

The oxysterol dendrogenin A increases the activation of migratory dendritic cells by acting through the LXRβ.

Julio Buñay , Laly Pucheu , Silia Ayadi , Michel Record , Philippe de Medina et al.
12th ENOR symposium, Importance of Oxysterols in Nutrition, Cancer, and Other Degenerative Diseases, ENOR, Sep 2023, Toulouse, France
Communication dans un congrès inserm-05029673 v1

Synthesis and cellular evaluation of new bi-specific estrogen receptor modulators and ACAT/SOAT inhibitors as anticancer agents

Farid Khallouki , M Poirot , Stéphanie Caze-Subra , Kerstin Bystricky , Sandrine Silvente-Poirot et al.
12th ENOR symposium, Importance of Oxysterols in Nutrition, Cancer, and Other Degenerative Diseases, ENOR, Sep 2023, Toulouse, France
Communication dans un congrès inserm-05029726 v1

Discovery of a new metabolic branch on the cholesterol pathway: importance in cancers and other diseases

M Poirot , Sandrine Silvente-Poirot
Smith-Lemli-Opitz Conferences, SLO foundation, Jun 2023, Seattle, United States
Communication dans un congrès inserm-05029087 v1

The 5,6-epoxycholesterol metabolic branch: possible involvement in aging and degenerative diseases

M Poirot , Sandrine Silvente-Poirot
invited conference, Bruce D Hammock, Jan 2023, Davis (virtual conference), United States
Communication dans un congrès inserm-05029116 v1

Combined OCDO/DDA extraction and quantification method for a fast and accurate HPLC-MS analysis

Regis Soules , Philippe de Medina , Silia Ayadi , Étienne Chatelut , Sandrine Silvente-Poirot et al.
12th ENOR symposium, Importance of Oxysterols in Nutrition, Cancer, and Other Degenerative Diseases, ENOR, Sep 2023, Toulouse, France
Communication dans un congrès inserm-05029741 v1

GSTA1-1 is a multifunctional enzyme involved in 5,6α-epoxycholesterol conjugation with biological nucleophiles

Silia Ayadi , Georges Ndikoum-Matip , Philippe de Medina , Virginie Nahoum , Laurent Maveyraud et al.
11th ENOR symposium, ENOR, Sep 2022, Oslo, Norway
Communication dans un congrès inserm-05029750 v1

A combined OCDO/DDA extraction and quantification method for a fast and accurate determination of a carcinogenic metabolic deregulation in patients

Regis Soules , Étienne Chatelut , Sandrine Silvente-Poirot , M Poirot , Ben Allal
11th ENOR symposium, ENOR, Sep 2022, Oslo, Norway
Communication dans un congrès inserm-05029775 v1

Reprogramming tumor cells with the oxysterol, dendrogenin A, to release immunogenic anti-tumor small extracellular vesicles enriched in exosomes.

Julio Buñay , Michel Record , Laly Pucheu , M Poirot , Philippe de Medina et al.
11th ENOR symposium, ENOR, Sep 2022, Oslo, Norway
Communication dans un congrès inserm-05029772 v1

Comparative Studies on the metabolism of 5,6-epoxycholesterol, cholestane-3β,5α,6β-triol and Oncosterone in the cancer cell lines MCF-7, MDA-MB-231 and HEPG2.

Philippe de Medina , Silia Ayadi , Dieter Lütjohann , Sandrine Silvente-Poirot , M Poirot
11th ENOR symposium, ENOR, Sep 2022, Oslo, Norway
Communication dans un congrès inserm-05029763 v1

Chemical synthesis and biological properties of cholestane-5α,6β-diol-3-sulfonate, a non-hydrolyzable analogue of cholestane-5α,6β-diol-3-O-sulfate

Philippe de Medina , Mohammad Samadi , Silia Ayadi , Sandrine Rup-Jacques , Regis Soules et al.
11th ENOR symposium (European Network for Oxysterol Research), ENOR, Sep 2022, Oslo, Norway
Communication dans un congrès inserm-05029757 v1

Side chain hydroxylation of cholestane-3β,5α,6β-triol and Oncosterone lead to the production of new endogenous oxysterols potentially involved in breast cancer development.

Tifany Lalande , Regis Soules , Sandrine Silvente-Poirot , Philippe de Medina , M Poirot
10th ENOR Symposium – Web Meeting, ENOR, Sep 2021, Web Conf, United Kingdom
Communication dans un congrès inserm-05029836 v1

Inhibition of oncosterone biosynthesis as a new pharmacological anticancer strategy in breast cancer.

Philippe de Medina , Rabea Bartölke , Regis Soules , Sandrine Silvente-Poirot , M Poirot
10th ENOR Symposium – Web Meeting, ENOR, Sep 2021, Web Conf, United Kingdom
Communication dans un congrès inserm-05029843 v1

Characterization of a cholesterol metabolic switch controlling breast carcinogenesis

M Poirot , Sandrine Silvente-Poirot
10th ENOR annual symposium, ENOR, Sep 2021, Oslo / Virtual, Norway
Communication dans un congrès inserm-05029135 v1

Characterization of a cholesterol metabolic switch controlling breast carcinogenesis

Philippe de Medina , Silia Ayadi , Emmanuel Noguer , Lisa Barrett , Regis Soules et al.
10th ENOR Symposium – Web Meeting, ENOR, Sep 2021, Web Conf, United Kingdom
Communication dans un congrès inserm-05029820 v1

New targeting in oxysterol metabolism for triple negative breast cancer therapy.

Khadijetou Diallo , Philippe de Medina , Regis Soules , Laly Pucheu , Arnaud Mallinger et al.
10th ENOR Symposium – Web Meeting, ENOR, Sep 2021, Web Conf, United Kingdom
Communication dans un congrès inserm-05029825 v1

Biochemical and pharmacological characterization of the enzyme responsible for the biosynthesis of 6-oxo-cholestan-3β-5α-diol (OCDO), a carcinogenic oxysterol

M Poirot , Sandrine Silvente-Poirot
9th ENOR SYMPOSIUM, Metabolism and Oxysterols: Therapeutics for Lifelong Health, ENOR, Sep 2019, Edinbourg, Ecosse, United Kingdom
Communication dans un congrès inserm-05029857 v1

Biochemical and pharmacological characterization of the enzyme responsible for the biosynthesis of 6-oxo-cholestan-3β-5α-diol (OCDO), a carcinogenic oxysterol

M Poirot , Sandrine Silvente-Poirot
9th ENOR SYMPOSIUM, Metabolism and Oxysterols: Therapeutics for Lifelong Health, ENOR, Sep 2019, Edimburgh, Scotland, United Kingdom
Communication dans un congrès inserm-05029141 v1

An oxysterol oncometabolite and glucocorticoid receptor signaling in triple negative breast cancer cell proliferation.

Arnaud Mallinger , Khadijetou Diallo , M Poirot , Sandrine Silvente-Poirot
9th ENOR SYMPOSIUM, Metabolism and Oxysterols: Therapeutics for Lifelong Health, ENOR, Sep 2019, Edinbourgh (Scotland), United Kingdom
Communication dans un congrès inserm-05029849 v1

Design, synthesis and cellular evaluation of new bi-specific estrogen receptor modulators and ACAT inhibitors as anticancer agents

Farid Khallouki , Guillaume Amouroux , Stéphanie Caze-Subra , Kerstin Bystricky , Patrick Balaguer et al.
9th ENOR SYMPOSIUM, Metabolism and Oxysterols: Therapeutics for Lifelong Health, ENOR, Sep 2019, Edinbourg, Ecosse, United Kingdom
Communication dans un congrès inserm-05029855 v1
Image document

The Cholesterol-5,6-Epoxide Hydrolase: A Metabolic Checkpoint in Several Diseases

Philippe de Medina , Silia Ayadi , Khadijetou Diallo , Julio Buñay , Laly Pucheu et al.
Implication of Oxysterols and Phytosterols in Aging and Human Diseases, 1440, Springer International Publishing, pp.149-161, 2024, Advances in Experimental Medicine and Biology, ⟨10.1007/978-3-031-43883-7_8⟩
Chapitre d'ouvrage inserm-04317348 v1
Image document

Vitamin E: an overview

Farid Khallouki , Robert Wyn Owen , Mourad Akdad , Bachir El Bouhali , Sandrine Silvente-Poirot et al.
Molecular Nutrition, Elsevier, pp.51-66, 2020, ⟨10.1016/B978-0-12-811907-5.00001-4⟩
Chapitre d'ouvrage inserm-03084874 v1